» Articles » PMID: 25956834

Lifestyle Intervention in Gastroesophageal Reflux Disease

Overview
Specialty Gastroenterology
Date 2015 May 10
PMID 25956834
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Gastroesophageal reflux disease (GERD) affects up to 30% of adults in Western populations and is increasing in prevalence. GERD is associated with lifestyle factors, particularly obesity and tobacco smoking, which also threatens the patient's general health. GERD carries the risk of several adverse outcomes and there is widespread use of potent acid-inhibitors, which are associated with long-term adverse effects. The aim of this systematic review was to assess the role of lifestyle intervention in the treatment of GERD.

Methods: Literature searches were performed in PubMed (from 1946), EMBASE (from 1980), and the Cochrane Library (no start date) to October 1, 2014. Meta-analyses, systematic reviews, randomized clinical trials (RCTs), and prospective observational studies were included.

Results: Weight loss was followed by decreased time with esophageal acid exposure in 2 RCTs (from 5.6% to 3.7% and from 8.0% to 5.5%), and reduced reflux symptoms in prospective observational studies. Tobacco smoking cessation reduced reflux symptoms in normal-weight individuals in a large prospective cohort study (odds ratio, 5.67). In RCTs, late evening meals increased time with supine acid exposure compared with early meals (5.2% point change), and head-of-the-bed elevation decreased time with supine acid exposure compared with a flat position (from 21% to 15%).

Conclusions: Weight loss and tobacco smoking cessation should be recommended to GERD patients who are obese and smoke, respectively. Avoiding late evening meals and head-of-the-bed elevation is effective in nocturnal GERD.

Citing Articles

American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: methodology and review of evidence.

Desai M, Ruan W, Thosani N, Amaris M, Scott J, Saeed A VideoGIE. 2025; 10(2):81-137.

PMID: 40012897 PMC: 11852708. DOI: 10.1016/j.vgie.2024.10.001.


Non-Pharmacological Management of Idiopathic Pulmonary Fibrosis.

Mullholand J, Grossman C, Perelas A J Clin Med. 2025; 14(4).

PMID: 40004847 PMC: 11856631. DOI: 10.3390/jcm14041317.


Evidence summary on management strategies for gastroesophageal reflux symptoms in patients following esophageal cancer surgery.

Zhao Y, Fu Y, Zhang W, Zhao S, Li H Asia Pac J Oncol Nurs. 2025; 12():100639.

PMID: 39811449 PMC: 11732502. DOI: 10.1016/j.apjon.2024.100639.


Psychological factors, lifestyle habits, and their association with gastroesophageal reflux disease among Egyptian university students: A cross-sectional study.

Ahmed H, Yousef A, El-Kurdy R, Murad M, Abdelwahab S, Shiba H Medicine (Baltimore). 2025; 103(47):e40477.

PMID: 39809207 PMC: 11596765. DOI: 10.1097/MD.0000000000040477.


Update Motility Disorders: Gastro-Oesophageal Reflux Disease - Diagnostic and Conservative Approach.

Fox M Visc Med. 2024; 40(6):299-309.

PMID: 39664098 PMC: 11631173. DOI: 10.1159/000541358.


References
1.
Hamilton J, Boisen R, Yamamoto D, Wagner J, Reichelderfer M . Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid. Dig Dis Sci. 1988; 33(5):518-22. DOI: 10.1007/BF01798350. View

2.
Kahrilas P, Gupta R . The effect of cigarette smoking on salivation and esophageal acid clearance. J Lab Clin Med. 1989; 114(4):431-8. View

3.
Kahrilas P, Quigley E . Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology. 1996; 110(6):1982-96. DOI: 10.1053/gast.1996.1101982. View

4.
Tytgat G . Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension. Eur J Gastroenterol Hepatol. 1996; 8(7):635-40. View

5.
Kjellin A, Ramel S, Rossner S, Thor K . Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol. 1996; 31(11):1047-51. DOI: 10.3109/00365529609036885. View